NDC 62332-213

Amlodipine besylate and Olmesartran medoxomil

Amlodipine Besylate And Olmesartran Medoxomil

Amlodipine besylate and Olmesartran medoxomil is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Amlodipine Besylate; Olmesartan Medoxomil.

• Product ID: 62332-213_0cbecf15-09ab-4270-bf17-39693989f36e
• NDC: 62332-213
• Product Type: Human Prescription Drug
• Proprietary Name: Amlodipine besylate and Olmesartran medoxomil
• Generic Name: Amlodipine Besylate And Olmesartran Medoxomil
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2017-07-18
• Marketing Category: ANDA / ANDA
• Application Number: ANDA207073
• Labeler Name: Alembic Pharmaceuticals Inc.
• Substance Name: AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
• Active Ingredient Strength: 5 mg/1; mg/1
• Pharm Classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 62332-213-30

30 TABLET, FILM COATED in 1 BOTTLE (62332-213-30)

• Marketing Start Date: 2017-07-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62332-213-90 [62332021390]

Amlodipine besylate and Olmesartran medoxomil TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA207073
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-07-18

NDC 62332-213-30 [62332021330]

Amlodipine besylate and Olmesartran medoxomil TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA207073
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-07-18

NDC 62332-213-91 [62332021391]

Amlodipine besylate and Olmesartran medoxomil TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA207073
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-07-18

Drug Details

Active Ingredients

Ingredient	Strength
AMLODIPINE BESYLATE	5 mg/1

OpenFDA Data

• SPL SET ID: 1eb78d80-701d-4766-98c3-feee6790de1a
• Manufacturer:
  • Alembic Pharmaceuticals Inc.
• UNII:
  • 6M97XTV3HD
  • 864V2Q084H
• RxNorm Concept Unique ID - RxCUI:
  • 730872
  • 730861
  • 730866
  • 730869
• UPC Code:
  • 0362332213306
  • 0362332214303
  • 0362332212309
  • 0362332215300

Pharmacological Class

• Calcium Channel Antagonists [MoA]
• Dihydropyridine Calcium Channel Blocker [EPC]
• Dihydropyridines [CS]
• Angiotensin 2 Receptor Antagonists [MoA]
• Angiotensin 2 Receptor Blocker [EPC]

Medicade Reported Pricing

62332021330 AMLODIPINE-OLMESARTAN 5-40 MG

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Amlodipine besylate and Olmesartran medoxomil" or generic name "Amlodipine Besylate And Olmesartran Medoxomil"

NDC	Brand Name	Generic Name
46708-212	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
46708-213	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
46708-214	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
46708-215	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-212	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-213	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-214	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-215	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil